Tech Company Financing Transactions

Nodus Oncology Funding Round

Nodus Oncology secured a $2.9 million funding round on 2/7/2023. Backers included Cumulus Oncology and KHAN Technology Transfer Fund.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

61 Dublin Street Midlothian
Edinburgh, Scotland, EH3 6NL
UK

Phone

Undisclosed

Website

www.nodusoncology.com

Email Address

[email protected]

Overview

Nodus Oncology is developing first and best-in-class molecules inhibiting novel targets within the DNA damage response and replication stress response. Supported by most recent scientific advances, we are developing the next wave of cancer therapeutics in the DNA damage response (DDR) area. Founded by Cumulus Oncology and in partnership with the Lead Discovery Centre, Nodus Oncology is developing an innovative portfolio focused on synthetic lethality and collateral vulnerabilities in molecularly defined cancer patient populations.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Ian Waddell

        

Chief Financial Officer

Scott Doak

        

Chief Operating Officer

Manuelle Debunne

        

Chief Scientific Officer

Luis Toledo

        

Browse more venture capital transactions:

Prev: 2/6/2023: Quipli venture capital transaction
Next: 2/7/2023: Fabric8Labs venture capital transaction

Share this article

About Our VC Transactions Data

Our team works diligently to document all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary